MOMETASONE FUROATE

MOMETASONE FUROATE was reported 42731 times

These side effects are most commonly reported by patients taking MOMETASONE FUROATE:

# Side effect Count
0 NO ADVERSE EVENT 4853
1 PRODUCT QUALITY ISSUE 4526
2 DYSPNOEA 4038
3 DRUG INEFFECTIVE 3094
4 ASTHMA 2921
5 HEADACHE 2919
6 DRUG DOSE OMISSION 2907
7 POOR QUALITY DEVICE USED 2885
8 COUGH 2805
9 FATIGUE 2618
10 NAUSEA 2359
11 DEVICE MALFUNCTION 2157
12 WHEEZING 1958
13 PAIN 1935
14 PNEUMONIA 1788
15 OFF LABEL USE 1724
16 GASTROOESOPHAGEAL REFLUX DISEASE 1649
17 DIARRHOEA 1637
18 DIZZINESS 1507
19 SINUSITIS 1391
20 ARTHRALGIA 1385
21 ANXIETY 1381
22 MALAISE 1357
23 PRODUCT DOSE OMISSION ISSUE 1328
24 PRURITUS 1323
25 RASH 1316
26 HYPERSENSITIVITY 1282
27 VOMITING 1234
28 PYREXIA 1233
29 NASOPHARYNGITIS 1215
30 HYPERTENSION 1211
31 CHEST DISCOMFORT 1207
32 INSOMNIA 1190
33 ASTHENIA 1156
34 PAIN IN EXTREMITY 1101
35 FALL 1100
36 WEIGHT DECREASED 1084
37 CONDITION AGGRAVATED 1061
38 DEPRESSION 972
39 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 962
40 PRODUCTIVE COUGH 950
41 NASAL CONGESTION 940
42 SOMNOLENCE 889
43 BACK PAIN 876
44 CHEST PAIN 876
45 PRODUCT USE IN UNAPPROVED INDICATION 827
46 WEIGHT INCREASED 825
47 INCORRECT DOSE ADMINISTERED 815
48 DRUG HYPERSENSITIVITY 810
49 ABDOMINAL PAIN 803
50 MUSCLE SPASMS 775
51 DYSPHONIA 774
52 BLOOD PRESSURE INCREASED 772
53 CONSTIPATION 768
54 FEELING ABNORMAL 762
55 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 757
56 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 742
57 ERYTHEMA 730
58 DRUG INTOLERANCE 722
59 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 714
60 BRONCHITIS 711
61 OEDEMA PERIPHERAL 710
62 CHRONIC KIDNEY DISEASE 708
63 TREMOR 706
64 OBSTRUCTIVE AIRWAYS DISORDER 698
65 RHINORRHOEA 695
66 ABDOMINAL PAIN UPPER 675
67 INFLUENZA 674
68 URTICARIA 670
69 OROPHARYNGEAL PAIN 665
70 DYSPNOEA EXERTIONAL 627
71 DEATH 623
72 CARDIAC DISORDER 619
73 SLEEP APNOEA SYNDROME 619
74 PARAESTHESIA 618
75 GAIT DISTURBANCE 611
76 RHINITIS ALLERGIC 598
77 URINARY TRACT INFECTION 596
78 MYALGIA 594
79 PRODUCT DOSE OMISSION 579
80 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 578
81 UPPER RESPIRATORY TRACT INFECTION 577
82 INFECTION 573
83 PRODUCT USE ISSUE 573
84 FULL BLOOD COUNT ABNORMAL 569
85 PALPITATIONS 562
86 RENAL FAILURE 561
87 INJECTION SITE PAIN 557
88 HYPOAESTHESIA 556
89 ANAEMIA 551
90 BURNING SENSATION 546
91 SPUTUM DISCOLOURED 534
92 EPISTAXIS 528
93 DECREASED APPETITE 515
94 MIGRAINE 504
95 HEART RATE INCREASED 500
96 ACUTE KIDNEY INJURY 494
97 PRODUCT CONTAINER ISSUE 492
98 ATRIAL FIBRILLATION 487
99 SLEEP DISORDER 487
100 LOWER RESPIRATORY TRACT INFECTION 480
101 PERIPHERAL SWELLING 478
102 MUSCULOSKELETAL STIFFNESS 472
103 ALOPECIA 468
104 COVID-19 466
105 CHILLS 465
106 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 465
107 SWELLING FACE 463
108 HYPERHIDROSIS 456
109 OSTEOARTHRITIS 453
110 NASAL POLYPS 444
111 ABDOMINAL DISCOMFORT 441
112 BLOOD TEST ABNORMAL 435
113 HYPOTENSION 434
114 HOSPITALISATION 420
115 FIBROMYALGIA 419
116 JOINT SWELLING 418
117 PULMONARY EMBOLISM 409
118 HYPOTHYROIDISM 407
119 STRESS 403
120 GASTROINTESTINAL DISORDER 392
121 VISION BLURRED 389
122 MUSCULAR WEAKNESS 387
123 PNEUMONIA ASPIRATION 386
124 BRONCHIECTASIS 385
125 GENERAL PHYSICAL HEALTH DETERIORATION 369
126 ANGIOEDEMA 368
127 BLOOD CREATININE INCREASED 365
128 DYSPEPSIA 364
129 ARTHRITIS 361
130 NEUROPATHY PERIPHERAL 361
131 RHEUMATOID ARTHRITIS 361
132 SKIN EXFOLIATION 361
133 COMA 358
134 FLUSHING 358
135 ILLNESS 357
136 DRY SKIN 354
137 CARPAL TUNNEL SYNDROME 352
138 CONTUSION 351
139 SWOLLEN TONGUE 346
140 DEHYDRATION 345
141 LUNG DISORDER 344
142 DRY EYE 343
143 SWELLING 342
144 EMOTIONAL DISTRESS 338
145 CONFUSIONAL STATE 334
146 INFLUENZA LIKE ILLNESS 331
147 SINUS DISORDER 331
148 CATARACT 330
149 INJURY 330
150 ABDOMINAL DISTENSION 328
151 HAEMOPTYSIS 326
152 SYNCOPE 326
153 THROAT IRRITATION 326
154 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 324
155 RENAL DISORDER 323
156 HEPATIC ENZYME INCREASED 316
157 DRY MOUTH 311
158 DYSPHAGIA 307
159 VISUAL IMPAIRMENT 306
160 MEMORY IMPAIRMENT 304
161 MYOCARDIAL INFARCTION 304
162 CORONARY ARTERY DISEASE 300
163 CEREBROVASCULAR ACCIDENT 298
164 CHOLELITHIASIS 294
165 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 292
166 LOSS OF CONSCIOUSNESS 290
167 BALANCE DISORDER 289
168 DRUG INTERACTION 288
169 TYPE 2 DIABETES MELLITUS 287
170 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 286
171 SUICIDAL IDEATION 283
172 PSORIASIS 282
173 SEPSIS 281
174 POLYCYSTIC OVARIES 276
175 PLEURAL EFFUSION 274
176 UNDERDOSE 274
177 ECZEMA 273
178 RENAL IMPAIRMENT 273
179 SENSITISATION 273
180 TREATMENT FAILURE 270
181 DEEP VEIN THROMBOSIS 268
182 ADVERSE EVENT 265
183 CELLULITIS 263
184 DYSGEUSIA 258
185 NECK PAIN 258
186 EJECTION FRACTION 256
187 INTENTIONAL PRODUCT MISUSE 256
188 THROMBOSIS 256
189 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 255
190 INTENTIONAL PRODUCT USE ISSUE 255
191 DIABETES MELLITUS 252
192 HYPOXIA 250
193 OVERDOSE 250
194 INFUSION RELATED REACTION 248
195 SEASONAL ALLERGY 248
196 TACHYCARDIA 247
197 UPPER-AIRWAY COUGH SYNDROME 246
198 EOSINOPHILIA 245
199 RESPIRATORY TRACT INFECTION 245
200 SKIN LESION 245
201 BLOOD GLUCOSE INCREASED 244
202 HAEMOGLOBIN DECREASED 243
203 INJECTION SITE ERYTHEMA 242
204 OEDEMA 241
205 MUSCULOSKELETAL PAIN 240
206 OSTEOPENIA 238
207 ARTHROPATHY 236
208 EAR INFECTION 234
209 NEPHROLITHIASIS 234
210 OSTEOPOROSIS 234
211 VERTIGO 233
212 RHINITIS 230
213 DISCOMFORT 229
214 ANOSMIA 228
215 DEVICE DIFFICULT TO USE 228
216 CARDIAC FAILURE CONGESTIVE 227
217 ANAPHYLACTIC REACTION 226
218 HERPES ZOSTER 226
219 HOT FLUSH 225
220 CARDIAC MURMUR 222
221 SECRETION DISCHARGE 216
222 DEPRESSED MOOD 214
223 RALES 214
224 ILL-DEFINED DISORDER 213
225 EXOSTOSIS 212
226 OXYGEN SATURATION DECREASED 212
227 DERMATITIS ATOPIC 209
228 EYE PAIN 209
229 MIDDLE INSOMNIA 208
230 MOBILITY DECREASED 208
231 BLOOD CHOLESTEROL INCREASED 207
232 RESPIRATORY TRACT CONGESTION 207
233 FEELING HOT 206
234 ACCIDENTAL EXPOSURE TO PRODUCT 205
235 SNEEZING 205
236 RASH PRURITIC 203
237 SEIZURE 201
238 END STAGE RENAL DISEASE 200
239 OBESITY 199
240 CYST 198
241 TRANSIENT ISCHAEMIC ATTACK 198
242 BLISTER 197
243 EAR PAIN 195
244 THERAPEUTIC RESPONSE DECREASED 194
245 NEURALGIA 193
246 OBSTRUCTIVE SLEEP APNOEA SYNDROME 192
247 SARCOIDOSIS 192
248 SKIN BURNING SENSATION 192
249 SURGERY 192
250 UNEVALUABLE EVENT 192
251 VIRAL INFECTION 192
252 FLUID RETENTION 190
253 BLOOD PRESSURE DECREASED 189
254 CROHN^S DISEASE 189
255 TINNITUS 188
256 GASTROINTESTINAL HAEMORRHAGE 185
257 STOMATITIS 184
258 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 183
259 PANIC ATTACK 183
260 SPEECH DISORDER 182
261 BLOOD PRESSURE SYSTOLIC INCREASED 180
262 LUNG NEOPLASM MALIGNANT 180
263 WHITE BLOOD CELL COUNT DECREASED 180
264 ADVERSE DRUG REACTION 179
265 HALLUCINATION 179
266 BREAST CANCER 177
267 HYPERLIPIDAEMIA 177
268 OCULAR HYPERAEMIA 177
269 PULMONARY FIBROSIS 177
270 PULMONARY MASS 177
271 AMNESIA 175
272 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 173
273 DRUG DEPENDENCE 173
274 ALANINE AMINOTRANSFERASE INCREASED 172
275 DYSURIA 171
276 THERAPEUTIC RESPONSE UNEXPECTED 171
277 INJECTION SITE BRUISING 170
278 HYPERGLYCAEMIA 169
279 RASH ERYTHEMATOUS 168
280 BONE PAIN 167
281 HYPONATRAEMIA 166
282 PRODUCT AVAILABILITY ISSUE 166
283 RESPIRATORY FAILURE 166
284 ANHEDONIA 165
285 SINUS CONGESTION 165
286 BLOOD COUNT ABNORMAL 164
287 DEAFNESS NEUROSENSORY 164
288 EOSINOPHIL COUNT INCREASED 164
289 FLATULENCE 163
290 ASPIRATION 162
291 CHRONIC SINUSITIS 162
292 DYSARTHRIA 162
293 LYMPHADENOPATHY 161
294 INJECTION SITE SWELLING 160
295 NERVOUSNESS 160
296 POLLAKIURIA 160
297 RESPIRATORY DISORDER 160
298 SKIN DISCOLOURATION 160
299 DISEASE RECURRENCE 159
300 HAEMORRHAGE 159
301 HYPOKALAEMIA 159
302 IRRITABILITY 159
303 NASAL DISCOMFORT 158
304 TOTAL LUNG CAPACITY INCREASED 158
305 EYE SWELLING 156
306 SENSATION OF FOREIGN BODY 156
307 LIMB INJURY 155
308 BRONCHOSPASM 154
309 AGITATION 153
310 JOINT INJURY 153
311 MEDICATION ERROR 153
312 ASPARTATE AMINOTRANSFERASE INCREASED 152
313 EYE IRRITATION 151
314 INFLAMMATION 150
315 INJECTION SITE PRURITUS 149
316 PSYCHOTIC DISORDER 149
317 PLATELET COUNT DECREASED 148
318 RIB FRACTURE 148
319 AGGRESSION 147
320 PLEURAL FIBROSIS 147
321 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 146
322 GLAUCOMA 145
323 PLANTAR FASCIITIS 145
324 EXPOSURE DURING PREGNANCY 144
325 RENAL INJURY 144
326 AGEUSIA 143
327 THROAT TIGHTNESS 143
328 TRANSAMINASES INCREASED 141
329 HEART RATE DECREASED 140
330 MATERNAL EXPOSURE DURING PREGNANCY 140
331 THROMBOCYTOPENIA 140
332 LIVER FUNCTION TEST INCREASED 139
333 BLOOD CALCIUM INCREASED 138
334 DRUG ADMINISTRATION ERROR 138
335 EPIGASTRIC DISCOMFORT 138
336 LACRIMATION INCREASED 138
337 PANCREATITIS 138
338 PLEURAL THICKENING 138
339 ANGINA PECTORIS 137
340 ECONOMIC PROBLEM 137
341 HYPERCHOLESTEROLAEMIA 137
342 BLOOD BILIRUBIN INCREASED 136
343 PRE-EXISTING CONDITION IMPROVED 136
344 NEPHROGENIC ANAEMIA 135
345 PNEUMOTHORAX 135
346 PRESBYACUSIS 135
347 DISTURBANCE IN ATTENTION 134
348 HYPOACUSIS 134
349 EXPIRED PRODUCT ADMINISTERED 133
350 GOUT 133
351 MENTAL DISORDER 133
352 BLOOD POTASSIUM INCREASED 132
353 DEVICE DISLOCATION 132
354 INJECTION SITE REACTION 132
355 LUNG OPACITY 132
356 PLEURITIC PAIN 132
357 BRAIN NATRIURETIC PEPTIDE INCREASED 131
358 ABNORMAL BEHAVIOUR 130
359 CARDIAC FAILURE 130
360 EYE PRURITUS 130
361 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 129
362 HAEMATOCHEZIA 128
363 HEAD INJURY 128
364 INTERVERTEBRAL DISC PROTRUSION 128
365 WHITE BLOOD CELL COUNT INCREASED 128
366 DISORIENTATION 125
367 STAPHYLOCOCCAL INFECTION 125
368 BREATH SOUNDS ABNORMAL 124
369 CONJUNCTIVITIS 124
370 CRYING 124
371 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 124
372 PULMONARY OEDEMA 124
373 DISEASE PROGRESSION 123
374 FOOT FRACTURE 123
375 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 123
376 NIGHT SWEATS 123
377 PHARYNGITIS 123
378 ROAD TRAFFIC ACCIDENT 123
379 VASCULITIS 123
380 LETHARGY 122
381 FEELING COLD 121
382 HEPATOTOXICITY 121
383 INCREASED UPPER AIRWAY SECRETION 121
384 MYOGLOBIN BLOOD INCREASED 121
385 HEART RATE IRREGULAR 120
386 HIATUS HERNIA 120
387 RASH MACULAR 120
388 DYSKINESIA 119
389 ARRHYTHMIA 118
390 CYSTITIS 118
391 DEVICE ISSUE 118
392 DIVERTICULITIS 118
393 INJECTION SITE HAEMORRHAGE 118
394 ACNE 117
395 CONVULSION 117
396 DRUG EFFECT DECREASED 117
397 TOTAL LUNG CAPACITY DECREASED 116
398 TREATMENT NONCOMPLIANCE 116
399 CARDIAC ARREST 115
400 POOR QUALITY SLEEP 115
401 APHONIA 114
402 BLOOD POTASSIUM DECREASED 114
403 FEBRILE NEUTROPENIA 114
404 PRODUCT DELIVERY MECHANISM ISSUE 114
405 SKIN WEEPING 114
406 JAUNDICE CHOLESTATIC 113
407 PULMONARY CONGESTION 113
408 BURSITIS 112
409 LIVER DISORDER 112
410 BACTERIAL INFECTION 111
411 HAEMATURIA 111
412 ORAL CANDIDIASIS 111
413 PULMONARY FUNCTION TEST DECREASED 111
414 RESTLESS LEGS SYNDROME 111
415 SCHIZOPHRENIA 111
416 ANGER 110
417 THERAPEUTIC PRODUCT EFFECT DECREASED 109
418 BLOOD MAGNESIUM INCREASED 108
419 CANDIDA INFECTION 108
420 GASTRITIS 107
421 MOVEMENT DISORDER 107
422 PAIN IN JAW 107
423 PRODUCT SUBSTITUTION ISSUE 107
424 FOOD ALLERGY 106
425 FUNGAL INFECTION 106
426 IRRITABLE BOWEL SYNDROME 106
427 BODY TEMPERATURE INCREASED 105
428 IMPAIRED HEALING 105
429 MOOD SWINGS 105
430 PHARMACEUTICAL PRODUCT COMPLAINT 105
431 URINARY INCONTINENCE 105
432 FORCED EXPIRATORY VOLUME DECREASED 104
433 RENAL FAILURE ACUTE 104
434 BLOOD ALKALINE PHOSPHATASE INCREASED 103
435 COLITIS 103
436 DEVICE BREAKAGE 103
437 SINUS PAIN 103
438 BLOOD URINE PRESENT 102
439 DUST ALLERGY 102
440 FLANK PAIN 102
441 HYPOMANIA 102
442 CHOKING 101
443 WRONG TECHNIQUE IN DRUG USAGE PROCESS 101
444 BLOOD PRESSURE FLUCTUATION 100
445 MULTIPLE ALLERGIES 100
446 THERAPEUTIC RESPONSE SHORTENED 100
447 URINARY RETENTION 100
448 BODY TEMPERATURE DECREASED 99
449 EAR DISCOMFORT 99
450 NEUTROPENIA 99
451 PRODUCT TASTE ABNORMAL 99
452 RESTLESSNESS 99
453 SKIN DISORDER 99
454 RESPIRATORY DISTRESS 98
455 EYE DISORDER 97
456 HEAD DISCOMFORT 97
457 INTERVERTEBRAL DISC DEGENERATION 97
458 MALIGNANT NEOPLASM PROGRESSION 97
459 PSORIATIC ARTHROPATHY 97
460 RESPIRATION ABNORMAL 97
461 SYSTEMIC LUPUS ERYTHEMATOSUS 97
462 HYPOGLYCAEMIA 96
463 POOR QUALITY PRODUCT ADMINISTERED 96
464 SKIN ULCER 96
465 EJECTION FRACTION ABNORMAL 95
466 OSTEONECROSIS 95
467 TEMPERATURE INTOLERANCE 95
468 TOPICAL STEROID WITHDRAWAL REACTION 95
469 C-REACTIVE PROTEIN INCREASED 94
470 NODULE 94
471 PROCEDURAL PAIN 94
472 NIGHTMARE 93
473 CONTRAINDICATED PRODUCT ADMINISTERED 92
474 DIPLOPIA 92
475 EMOTIONAL DISORDER 92
476 LIMB DISCOMFORT 92
477 ORAL PAIN 92
478 ARTERIOSCLEROSIS 91
479 LUNG INFECTION 91
480 MUSCLE TWITCHING 91
481 NEPHRECTOMY 91
482 TENDONITIS 91
483 WRIST FRACTURE 91
484 BRONCHIAL OBSTRUCTION 90
485 GALLBLADDER DISORDER 90
486 PRESCRIBED OVERDOSE 90
487 RESPIRATORY SYMPTOM 90
488 SKIN FISSURES 90
489 ULCER 90
490 WOUND 90
491 ATELECTASIS 89
492 FEAR 89
493 GASTRIC DISORDER 89
494 GASTROENTERITIS VIRAL 89
495 HYPERSOMNIA 89
496 INCORRECT DOSE ADMINISTERED BY DEVICE 89
497 INFUSION SITE PAIN 89
498 RECTAL HAEMORRHAGE 89
499 TOXICITY TO VARIOUS AGENTS 89
500 BONE DENSITY DECREASED 87
501 COGNITIVE DISORDER 87
502 GASTROENTERITIS 87
503 LIP SWELLING 87
504 SKIN LACERATION 87
505 ACTIVITIES OF DAILY LIVING IMPAIRED 86
506 DEFORMITY 86
507 MUSCULOSKELETAL CHEST PAIN 86
508 ROTATOR CUFF SYNDROME 86
509 LIGAMENT SPRAIN 85
510 NEPHROPATHY 85
511 TUBULOINTERSTITIAL NEPHRITIS 85
512 DERMATITIS 84
513 LOCALISED INFECTION 84
514 VISUAL ACUITY REDUCED 84
515 BLOOD CREATINE PHOSPHOKINASE INCREASED 83
516 MITRAL VALVE INCOMPETENCE 83
517 APHASIA 82
518 ARTERIOSCLEROSIS CORONARY ARTERY 82
519 SCIATICA 82
520 ADRENAL INSUFFICIENCY 81
521 PANCYTOPENIA 81
522 SPINAL OSTEOARTHRITIS 81
523 ABNORMAL DREAMS 80
524 HAEMORRHOIDS 80
525 ORAL HERPES 80
526 PHARYNGEAL OEDEMA 79
527 PHOTOSENSITIVITY REACTION 79
528 BLOOD SODIUM DECREASED 78
529 PRESYNCOPE 78
530 VITAMIN D DEFICIENCY 78
531 ANAPHYLACTIC SHOCK 77
532 DERMATITIS CONTACT 77
533 DYSSTASIA 77
534 IMPAIRED QUALITY OF LIFE 77
535 NASAL DISORDER 77
536 NEOPLASM MALIGNANT 77
537 PAIN OF SKIN 77
538 PERICARDIAL EFFUSION 77
539 PRODUCT ODOUR ABNORMAL 77
540 BACK DISORDER 76
541 BRADYCARDIA 76
542 BRONCHIAL WALL THICKENING 76
543 BLOOD GLUCOSE DECREASED 75
544 COLITIS ULCERATIVE 75
545 DIVERTICULUM 75
546 OSTEOSCLEROSIS 75
547 PRODUCT PRESCRIBING ISSUE 75
548 PRURITUS GENERALISED 75
549 RETCHING 75
550 WITHDRAWAL SYNDROME 75
551 BLOOD PRESSURE ABNORMAL 74
552 EPILEPSY 74
553 INTESTINAL OBSTRUCTION 74
554 POST PROCEDURAL COMPLICATION 74
555 TOOTHACHE 74
556 BLOOD IRON DECREASED 73
557 CONJUNCTIVITIS ALLERGIC 73
558 HAEMATOMA 73
559 IMPAIRED GASTRIC EMPTYING 73
560 PSEUDOMONAS INFECTION 73
561 TOOTH DISORDER 73
562 CARDIOMEGALY 72
563 CHOLECYSTITIS CHRONIC 72
564 FEELING JITTERY 72
565 FEMUR FRACTURE 72
566 IMPAIRED WORK ABILITY 72
567 SKIN INFECTION 72
568 ACUTE MYOCARDIAL INFARCTION 71
569 DEVICE DEFECTIVE 71
570 DRUG WITHDRAWAL SYNDROME 71
571 ECCHYMOSIS 71
572 MUSCULOSKELETAL DISCOMFORT 71
573 MYASTHENIA GRAVIS 71
574 OROPHARYNGEAL DISCOMFORT 71
575 BENIGN PROSTATIC HYPERPLASIA 70
576 CARDIOMYOPATHY 70
577 DEAFNESS 70
578 HYPOAESTHESIA ORAL 70
579 LIVER FUNCTION TEST ABNORMAL 70
580 PULMONARY HYPERTENSION 70
581 QUALITY OF LIFE DECREASED 70
582 SKIN ATROPHY 70
583 BONE DISORDER 69
584 HEPATIC STEATOSIS 69
585 IMMUNE SYSTEM DISORDER 69
586 MICTURITION URGENCY 69
587 MULTIPLE SCLEROSIS RELAPSE 69
588 ATRIAL FLUTTER 68
589 EXERCISE TOLERANCE DECREASED 68
590 FREQUENT BOWEL MOVEMENTS 68
591 GAIT INABILITY 68
592 GAMMA-GLUTAMYLTRANSFERASE INCREASED 68
593 GLOSSODYNIA 68
594 INJECTION SITE MASS 68
595 TOOTH ABSCESS 68
596 ANKLE FRACTURE 67
597 CYSTIC FIBROSIS 67
598 INFUSION SITE SWELLING 67
599 INTENTIONAL DOSE OMISSION 67
600 LARYNGITIS 67
601 MOOD ALTERED 67
602 MOUTH ULCERATION 67
603 NEUTROPHIL COUNT DECREASED 67
604 CLOSTRIDIUM DIFFICILE INFECTION 66
605 HYPERPARATHYROIDISM SECONDARY 66
606 LOWER LIMB FRACTURE 66
607 MYCOTIC ALLERGY 66
608 SCAB 66
609 SKIN PLAQUE 66
610 ACUTE RESPIRATORY FAILURE 65
611 BONE CYST 65
612 EMPHYSEMA 65
613 PAROSMIA 65
614 PHOTOPHOBIA 65
615 POST-TRAUMATIC STRESS DISORDER 65
616 ABASIA 64
617 BLOOD LACTATE DEHYDROGENASE INCREASED 64
618 HERNIA 64
619 HYPOKINESIA 64
620 LEUKOCYTOSIS 64
621 MULTIPLE SCLEROSIS 64
622 RED BLOOD CELL COUNT DECREASED 64
623 SCAR 64
624 THERAPY INTERRUPTED 64
625 THINKING ABNORMAL 64
626 BIPOLAR DISORDER 63
627 INCORRECT ROUTE OF DRUG ADMINISTRATION 63
628 INFUSION SITE ERYTHEMA 63
629 MENTAL STATUS CHANGES 63
630 NASAL CRUSTING 63
631 NASAL DRYNESS 63
632 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 63
633 RESPIRATORY RATE INCREASED 63
634 SINUS HEADACHE 63
635 THERAPY CESSATION 63
636 IMMUNODEFICIENCY 62
637 JAUNDICE 62
638 SEPTIC SHOCK 62
639 THIRST 62
640 THYROID DISORDER 62
641 ANOREXIA 61
642 FOETAL EXPOSURE DURING PREGNANCY 61
643 MITE ALLERGY 61
644 ORAL DISCOMFORT 61
645 PARAESTHESIA ORAL 61
646 TRICUSPID VALVE INCOMPETENCE 61
647 BLINDNESS 60
648 HIP FRACTURE 60
649 KIDNEY INFECTION 60
650 MASS 60
651 PARANASAL SINUS DISCOMFORT 60
652 RASH GENERALISED 60
653 SPIROMETRY ABNORMAL 60
654 CHROMATURIA 59
655 DEPRESSED LEVEL OF CONSCIOUSNESS 59
656 DRUG EFFECT INCOMPLETE 59
657 DRY THROAT 59
658 EXTRA DOSE ADMINISTERED 59
659 INTERSTITIAL LUNG DISEASE 59
660 INTRAOCULAR PRESSURE INCREASED 59
661 METASTASES TO BONE 59
662 SCRATCH 59
663 SENSORY DISTURBANCE 59
664 SKIN HAEMORRHAGE 59
665 TENOSYNOVITIS 59
666 UPPER LIMB FRACTURE 59
667 VITREOUS FLOATERS 59
668 ASTHENOPIA 58
669 COELIAC DISEASE 58
670 GLUCOSE TOLERANCE IMPAIRED 58
671 INJECTION SITE URTICARIA 58
672 PALLOR 58
673 PRODUCT PHYSICAL ISSUE 58
674 SNORING 58
675 VAGINAL HAEMORRHAGE 58
676 APPETITE DISORDER 57
677 EAR CONGESTION 57
678 EXPOSURE VIA SKIN CONTACT 57
679 MENTAL IMPAIRMENT 57
680 NERVOUS SYSTEM DISORDER 57
681 PRODUCT ADMINISTRATION INTERRUPTED 57
682 TARDIVE DYSKINESIA 57
683 TENDERNESS 57
684 CARDIOVASCULAR DISORDER 56
685 CONCUSSION 56
686 INCREASED BRONCHIAL SECRETION 56
687 IRON DEFICIENCY ANAEMIA 56
688 MUSCLE STRAIN 56
689 NERVE COMPRESSION 56
690 OSTEONECROSIS OF JAW 56
691 PNEUMONITIS 56
692 PRODUCT DOSE OMISSION IN ERROR 56
693 VENTRICULAR EXTRASYSTOLES 56
694 BACK INJURY 55
695 EYE INFECTION 55
696 HAEMATOCRIT DECREASED 55
697 HEREDITARY ANGIOEDEMA 55
698 HYPERKALAEMIA 55
699 NOCTURIA 55
700 NORMOCHROMIC NORMOCYTIC ANAEMIA 55
701 PHARYNGEAL SWELLING 55
702 REBOUND ACID HYPERSECRETION 55
703 RHABDOMYOLYSIS 55
704 SKIN CANCER 55
705 SPINAL FRACTURE 55
706 TOOTH FRACTURE 55
707 TROPONIN INCREASED 55
708 WOUND INFECTION 55
709 CLOSTRIDIUM DIFFICILE COLITIS 54
710 DISABILITY 54
711 HYPOPHOSPHATAEMIA 54
712 INCORRECT PRODUCT ADMINISTRATION DURATION 54
713 LEUKOPENIA 54
714 LYMPHOCYTE COUNT DECREASED 54
715 POOR QUALITY DRUG ADMINISTERED 54
716 PRODUCT LEAKAGE 54
717 RASH MACULO-PAPULAR 54
718 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 54
719 SUICIDE ATTEMPT 54
720 TACHYARRHYTHMIA 54
721 TOOTH INFECTION 54
722 ACCIDENTAL OVERDOSE 53
723 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 53
724 CHOLECYSTECTOMY 53
725 EATING DISORDER 53
726 ERECTILE DYSFUNCTION 53
727 HEPATITIS 53
728 HUNGER 53
729 POOR VENOUS ACCESS 53
730 RENAL CYST 53
731 VITAMIN D DECREASED 53
732 APPLICATION SITE PAIN 52
733 BLOOD PRESSURE DIASTOLIC ABNORMAL 52
734 BRONCHOPULMONARY ASPERGILLOSIS 52
735 DECREASED ACTIVITY 52
736 DIZZINESS POSTURAL 52
737 DRUG PRESCRIBING ERROR 52
738 INITIAL INSOMNIA 52
739 NASAL OEDEMA 52
740 NEURITIS 52
741 NEUROLOGICAL SYMPTOM 52
742 POLYP 52
743 SKIN IRRITATION 52
744 TENDON RUPTURE 52
745 ALLERGY TO ANIMAL 51
746 COLD SWEAT 51
747 DENTAL CARIES 51
748 EAR DISORDER 51
749 EXTRAPYRAMIDAL DISORDER 51
750 FACIAL PAIN 51
751 HYPERVENTILATION 51
752 INCREASED TENDENCY TO BRUISE 51
753 INJECTION SITE RASH 51
754 JOINT RANGE OF MOTION DECREASED 51
755 MUSCLE TIGHTNESS 51
756 NERVE INJURY 51
757 PSYCHOLOGICAL TRAUMA 51
758 PSYCHOMOTOR HYPERACTIVITY 51
759 RASH PAPULAR 51
760 STEROID WITHDRAWAL SYNDROME 51
761 ACCIDENT 50
762 ASTHMATIC CRISIS 50
763 BASAL CELL CARCINOMA 50
764 BLOOD PRESSURE DIASTOLIC INCREASED 50
765 BLOOD TRIGLYCERIDES INCREASED 50
766 CHOLECYSTITIS 50
767 DEVICE LEAKAGE 50
768 DRUG EXPOSURE DURING PREGNANCY 50
769 INCREASED APPETITE 50
770 JOINT STIFFNESS 50
771 KNEE ARTHROPLASTY 50
772 METASTASES TO LYMPH NODES 50
773 MULTIPLE ORGAN DYSFUNCTION SYNDROME 50
774 MYOPATHY 50
775 PHARYNGITIS STREPTOCOCCAL 50
776 ARTHROPOD BITE 49
777 BRONCHITIS CHRONIC 49
778 COAGULOPATHY 49
779 CORONARY ARTERY OCCLUSION 49
780 HAND FRACTURE 49
781 LUNG NEOPLASM 49
782 PAINFUL RESPIRATION 49
783 PARKINSON^S DISEASE 49
784 RHINALGIA 49
785 ABDOMINAL PAIN LOWER 48
786 ADJUSTMENT DISORDER 48
787 APPLICATION SITE ERYTHEMA 48
788 BODY HEIGHT DECREASED 48
789 CEREBRAL HAEMORRHAGE 48
790 HYPOPHAGIA 48
791 JOINT DISLOCATION 48
792 LOCAL SWELLING 48
793 ASCITES 47
794 BRAIN FOG 47
795 CONGENITAL HIATUS HERNIA 47
796 DEPRESSIVE SYMPTOM 47
797 INSURANCE ISSUE 47
798 TEMPERATURE REGULATION DISORDER 47
799 UNRESPONSIVE TO STIMULI 47
800 BLOOD UREA INCREASED 46
801 DELIRIUM 46
802 LABORATORY TEST ABNORMAL 46
803 LEFT VENTRICULAR DYSFUNCTION 46
804 OCULAR DISCOMFORT 46
805 ORTHOSTATIC HYPOTENSION 46
806 OSTEOMYELITIS 46
807 PROLONGED EXPIRATION 46
808 SKIN SWELLING 46
809 UTERINE LEIOMYOMA 46
810 ADVERSE REACTION 45
811 ERUCTATION 45
812 HEMIPARESIS 45
813 NASAL SEPTUM DEVIATION 45
814 PARANOIA 45
815 PRODUCT PRESCRIBING ERROR 45
816 SENSITIVITY TO WEATHER CHANGE 45
817 GASTRIC ULCER 44
818 INFUSION SITE PRURITUS 44
819 INTERNATIONAL NORMALISED RATIO INCREASED 44
820 LARGE INTESTINE POLYP 44
821 MENORRHAGIA 44
822 MULTIPLE FRACTURES 44
823 PERIPHERAL COLDNESS 44
824 POLYMYALGIA RHEUMATICA 44
825 PULMONARY ALVEOLAR HAEMORRHAGE 44
826 RENAL FAILURE CHRONIC 44
827 ROSACEA 44
828 SARS-COV-2 TEST POSITIVE 44
829 ABORTION SPONTANEOUS 43
830 ASTHMA EXERCISE INDUCED 43
831 CREPITATIONS 43
832 ELECTROLYTE IMBALANCE 43
833 GINGIVAL BLEEDING 43
834 HALLUCINATION, AUDITORY 43
835 LUNG INFILTRATION 43
836 MENIERE^S DISEASE 43
837 PULMONARY ARTERIAL HYPERTENSION 43
838 SCOLIOSIS 43
839 CANDIDIASIS 42
840 CARDIO-RESPIRATORY ARREST 42
841 CATAPLEXY 42
842 DIVERTICULUM INTESTINAL 42
843 HEART SOUNDS 42
844 HIP ARTHROPLASTY 42
845 HYPERPHOSPHATAEMIA 42
846 INCORRECT DRUG ADMINISTRATION DURATION 42
847 INTENTIONAL DRUG MISUSE 42
848 MACULAR DEGENERATION 42
849 PLASMA CELL MYELOMA 42
850 VARICOSE VEIN 42
851 DERMATITIS ALLERGIC 41
852 DRUG ERUPTION 41
853 EJECTION FRACTION DECREASED 41
854 GESTATIONAL DIABETES 41
855 HAEMATEMESIS 41
856 PNEUMONIA BACTERIAL 41
857 PRODUCT DISPENSING ERROR 41
858 PYELONEPHRITIS 41
859 SEROTONIN SYNDROME 41
860 SOMNAMBULISM 41
861 SPINAL COLUMN STENOSIS 41
862 STREPTOCOCCAL INFECTION 41
863 THERAPY NON-RESPONDER 41
864 BLOOD IMMUNOGLOBULIN E INCREASED 40
865 BLOOD PRESSURE DIASTOLIC DECREASED 40
866 DEMENTIA 40
867 DIABETES MELLITUS INADEQUATE CONTROL 40
868 DRUG DOSE OMISSION BY DEVICE 40
869 FEEDING DISORDER 40
870 GLYCOSYLATED HAEMOGLOBIN INCREASED 40
871 HEPATIC CYST 40
872 INJECTION SITE WARMTH 40
873 LIPASE INCREASED 40
874 OBSESSIVE-COMPULSIVE DISORDER 40
875 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 40
876 SINUS POLYP 40
877 UPPER GASTROINTESTINAL HAEMORRHAGE 40
878 WOUND COMPLICATION 40
879 WOUND SECRETION 40
880 BLADDER PAIN 39
881 BREAST PAIN 39
882 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 39
883 FAECES DISCOLOURED 39
884 HAIR TEXTURE ABNORMAL 39
885 HELICOBACTER INFECTION 39
886 LIGAMENT RUPTURE 39
887 MADAROSIS 39
888 MUSCLE ATROPHY 39
889 SINUS BRADYCARDIA 39
890 ANIMAL SCRATCH 38
891 CLAVICLE FRACTURE 38
892 FOLLICULITIS 38
893 HAIR COLOUR CHANGES 38
894 HEART RATE ABNORMAL 38
895 HYPERCALCAEMIA 38
896 MALIGNANT MELANOMA STAGE 0 38
897 MELAENA 38
898 PRODUCT ADMINISTRATION ERROR 38
899 PRODUCT DISTRIBUTION ISSUE 38
900 PRODUCT PACKAGING ISSUE 38
901 PULMONARY VASCULITIS 38
902 SKIN WRINKLING 38
903 SPINAL COMPRESSION FRACTURE 38
904 SPINAL OPERATION 38
905 TASTE DISORDER 38
906 TRIGGER FINGER 38
907 TUNNEL VISION 38
908 WEIGHT FLUCTUATION 38
909 ATAXIA 37
910 CYANOSIS 37
911 DELUSION 37
912 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 37
913 HYPERAESTHESIA 37
914 LOW DENSITY LIPOPROTEIN INCREASED 37
915 MASTICATION DISORDER 37
916 MUSCULOSKELETAL DISORDER 37
917 OBSTRUCTION 37
918 OVARIAN CYST 37
919 PANCREATITIS ACUTE 37
920 PELVIC PAIN 37
921 SPUTUM INCREASED 37
922 TENDON DISORDER 37
923 ANTICOAGULANT THERAPY 36
924 APNOEA 36
925 BLOOD CALCIUM DECREASED 36
926 BLOOD GLUCOSE ABNORMAL 36
927 BLOOD MAGNESIUM DECREASED 36
928 BODY TEMPERATURE ABNORMAL 36
929 BONE LOSS 36
930 DIASTOLIC DYSFUNCTION 36
931 DYSPNOEA AT REST 36
932 ELECTROCARDIOGRAM QT PROLONGED 36
933 FACTOR V LEIDEN MUTATION 36
934 INGUINAL HERNIA 36
935 MULTIPLE INJURIES 36
936 PETECHIAE 36
937 PROSTATE CANCER 36
938 VIRAL UPPER RESPIRATORY TRACT INFECTION 36
939 ACUTE SINUSITIS 35
940 ALVEOLAR OSTEITIS 35
941 ANTACID THERAPY 35
942 ARTERIAL OCCLUSIVE DISEASE 35
943 BLEPHAROSPASM 35
944 FACE OEDEMA 35
945 GINGIVAL PAIN 35
946 HEPATIC CIRRHOSIS 35
947 MUSCLE SPASTICITY 35
948 PROTEINURIA 35
949 SEDATION 35
950 SUPRAVENTRICULAR TACHYCARDIA 35
951 VENTRICULAR TACHYCARDIA 35
952 ANALGESIC THERAPY 34
953 BEDRIDDEN 34
954 BREAST MASS 34
955 DIABETIC NEUROPATHY 34
956 DRUG THERAPY 34
957 FOREIGN BODY IN THROAT 34
958 FORMICATION 34
959 GLOSSITIS 34
960 HAIR DISORDER 34
961 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 34
962 LEUKAEMIA 34
963 MAJOR DEPRESSION 34
964 NEEDLE ISSUE 34
965 PHARYNGOLARYNGEAL PAIN 34
966 RENAL PAIN 34
967 RIGHT VENTRICULAR FAILURE 34
968 SPINAL PAIN 34
969 TOOTH LOSS 34
970 URINARY TRACT DISCOMFORT 34
971 ABSCESS 33
972 COVID-19 PNEUMONIA 33
973 CUSHING^S SYNDROME 33
974 DRUG EFFECT LESS THAN EXPECTED 33
975 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 33
976 ENURESIS 33
977 GASTROINTESTINAL PAIN 33
978 HYSTERECTOMY 33
979 INFUSION SITE HAEMORRHAGE 33
980 INTENTIONAL OVERDOSE 33
981 LACERATION 33
982 LUNG HYPERINFLATION 33
983 NASAL OBSTRUCTION 33
984 PRODUCT STORAGE ERROR 33
985 SLEEP DISORDER THERAPY 33
986 THROMBOPHLEBITIS SUPERFICIAL 33
987 ATRIAL SEPTAL DEFECT 32
988 BLOOD PRESSURE SYSTOLIC ABNORMAL 32
989 GROIN PAIN 32
990 HYPERKERATOSIS 32
991 HYPERTHYROIDISM 32
992 HYPOVENTILATION 32
993 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 32
994 MUCOSAL INFLAMMATION 32
995 MYOCARDIAL ISCHAEMIA 32
996 NASAL DISCHARGE DISCOLOURATION 32
997 NO THERAPEUTIC RESPONSE 32
998 RHINITIS PERENNIAL 32
999 SPLENOMEGALY 32